This test is most useful if any of these apply to you.
If you eat a lot of corn, tortillas, cornmeal, or maize porridge, some of what you swallow may include an invisible mold toxin. This urine test tells you whether that toxin has recently entered your body, not just whether it sits on your food.
The result is a snapshot of the last few days, not a lifetime tally. That timing detail matters, and it shapes how you should read every number this test produces.
This test measures FB1 (fumonisin B1) in your urine. FB1 is a toxin made by Fusarium molds, a family of fungi that grow on maize and a few other crops. Your body does not make it. Every molecule detected came from food you ate.
Because your body absorbs only a small fraction of the FB1 you swallow, and clears it quickly, urine FB1 reflects recent internal exposure. Think of it as a window into what your gut absorbed over roughly the past few days, with levels peaking within a day of eating contaminated maize, not a measure of any organ function the way a glucose or kidney test works.
This is a research and biomonitoring marker rather than a standardized clinical test. There are no universally agreed cutoffs that define a healthy or unhealthy level, and a single reading should not drive medical decisions on its own. What it can do is show you whether fumonisin is currently getting into your body and whether steps to reduce exposure are working.
The reason to care about FB1 is what it does inside cells. FB1 closely resembles the building blocks of a class of fats called sphingolipids, which cells use for structure and signaling. Because of that resemblance, FB1 jams an enzyme called ceramide synthase that normally assembles these fats.
When that enzyme is blocked, raw materials pile up and finished products run short, throwing off signals that control cell growth, cell death, and tissue repair. In Guatemalan women, higher urine FB1 came alongside blood changes in these fat precursors, evidence that this disruption really happens in people at high exposure, not just in the lab.
Fumonisin causes liver and kidney tumors in rodents and is classified as possibly carcinogenic to humans. In people, the evidence is far softer. Communities that eat heavily contaminated maize tend to have higher rates of esophageal cancer, but these are population-level patterns, not proof that the toxin causes the disease in any one person.
The largest prospective human test to date is reassuring on its own terms. A case-cohort study in China followed roughly 866 people plus 240 people who developed esophageal cancer and found no clear link between baseline urine FB1 and later cancer, with a risk essentially unchanged from average (hazard ratio 0.94, meaning no meaningful difference from the comparison group). The null result held even after excluding the first two years of follow-up. The evidence is not entirely one-directional, though: a separate case-control study in China found higher urine fumonisin in people with esophageal squamous cell carcinoma than in controls.
What this means for you: a single detectable urine FB1 is not a cancer warning. The honest read is that this marker flags exposure, and exposure is worth reducing, but the human cancer link remains unproven and the studies disagree. Two earlier case-control studies of liver cancer also found no significant association.
In a group of young children in rural Tanzania, 80% had detectable urine FB1, and estimated intake in most exceeded international tolerable limits. Fumonisin exposure was tied to growth measures in that cohort, part of a broader concern that early-life exposure may affect development in maize-dependent settings.
Laboratory and mechanistic work also raises the possibility of neural tube defects, birth defects of the brain and spine, plausibly through the same disruption of sphingolipid production. This link is suggestive rather than settled in humans, but it is one reason pregnancy and early childhood draw extra attention in high-exposure regions.
In animals, fumonisin consistently damages the liver and kidneys and affects the brain, lungs, and immune system. Direct human organ-injury evidence tied to urine FB1 is limited, so the animal findings are best read as a reason to keep exposure low rather than as a diagnosis of harm in people.
A high result means your body recently absorbed fumonisin, almost always from maize. Because only a tiny share of what you eat shows up in urine, even modest readings can reflect real dietary intake. In Mexican women, those eating the most tortillas had roughly three times the urine FB1 of the lowest-intake group, and levels rose step by step with maize consumption.
A low or undetectable result usually means little recent exposure, or that any exposure happened several days earlier and has already cleared. It is not a deficiency, and it is not a clean bill of health for the past month. One controlled feeding study found FB1 vanished from urine within five days of stopping contaminated maize.
One threshold appears repeatedly in the research as a practical marker of intake. In Guatemalan women, a urine FB1 above 0.5 nanograms per milliliter (a unit for very small concentrations) meant a better than even chance of eating more fumonisin than international guidance considers tolerable. This is an exposure signal, not a disease line, and it is not a target your lab will hand you.
This marker rises fast after you eat contaminated maize and falls fast when you stop, so a single sample can easily miss intermittent exposure or catch an unusually high day. Only a small and variable fraction of intake reaches urine, which means small shifts in sampling or dilution can move the number without any real change in what you ate.
That volatility is exactly why a trend beats a snapshot. In a South African intervention, hand-sorting and washing maize cut estimated fumonisin intake by 62% and dropped creatinine-adjusted urine FB1 by 41%. In a controlled trial, green tea polyphenols lowered urine FB1 by 40% at 500 milligrams and 52.6% at 1,000 milligrams over three months. These changes are only visible if you have a baseline to compare against.
A workable rhythm is a baseline sample, a repeat sample within a few weeks if you are changing your diet or maize sources, and periodic rechecks after that. Because levels swing so much day to day, more than one sample gives a far more honest picture than any single reading. First-morning urine, adjusted for concentration using creatinine, is the standard collection approach used in the research.
The biggest source of confusion is not disease, it is how concentrated your urine is. Drinking a lot of fluid dilutes the sample and lowers the number, while a concentrated morning sample raises it, neither reflecting a real change in exposure. This is why labs adjust the result for creatinine, a substance that tracks how dilute the urine is.
A high reading is a prompt to look at your diet and maize sources, not to panic. The most useful next step is to repeat the test after adjusting what you eat and where your maize comes from, so you can see whether the number falls. Pairing a repeat sample with a food diary helps connect specific sources to your levels.
Because fumonisin rarely travels alone, it is often measured within a broader mycotoxin panel that also captures related mold toxins from grains. If you have persistent high exposure, ongoing digestive concerns, occupational contact with grain dust, or you are pregnant or caring for young children, a discussion with a clinician or toxicology specialist can help place the result in context. They can weigh your diet, sampling timing, and other markers together rather than reacting to one number in isolation.
Evidence-backed interventions that affect your FB1 level
Fumonisins B1 is best interpreted alongside these tests.
Fumonisins B1 is included in these pre-built panels.